<DOC>
	<DOCNO>NCT01983904</DOCNO>
	<brief_summary>The purpose study examine effect sub-callosal cingulate ( SCC ) deep brain stimulation ( DBS ) patient treatment resistant depression ( TRD ) . The working hypothesis long pulse-width DBS apply SCC region lead improvement TRD patient , specific neuroimaging biomarkers correlate response DBS ; functional recovery enhance concurrent cognitive behavioural therapy ( CBT ) .</brief_summary>
	<brief_title>DBS Treatment Resistant Depression</brief_title>
	<detailed_description>The aim collect data prediction , optimization augmentation DBS TRD develop tool DBS surgery . It biological pilot study design provide informative data future work .</detailed_description>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Depressive Disorder , Treatment-Resistant</mesh_term>
	<criteria>age 2070 diagnosis major depressive ( MDD ) bipolar disorder ( BP ) determine independently 2 study psychiatrist current major depressive episode &gt; 1 year duration , treatmentresistant ( meaning failure respond 4 different class antidepressant , include augmentation combination strategy lithium , atypical antipsychotic , anticonvulsant , antidepressant , evidencebased psychotherapy , CBT , electroconvulsive treatment despite adequate dosage , duration compliance ) minimum score 20 ( 52 ) 17 item Hamilton Depression Rating Scale ( HDRS ) resident Alberta , Canada , cover Alberta Health Axis I psychiatric disorder include schizophrenia , psychosis , active suicidal ideation previous 6 month cerebrovascular risk factor , previous stroke , head injury neurodegenerative disorder , pregnancy , medical general contraindication DBS surgery ( e.g . cardiac pacemaker/defibrillator ) age &gt; 70 diabetes</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>Major depressive disorder ( MDD )</keyword>
	<keyword>Bi-polar disorder ( BP )</keyword>
</DOC>